KEROS THERAPEUTICS INC (KROS) Institutional Shareholders

KEROS THERAPEUTICS INC (KROS) is currently reported in institutional portfolios tracked by InsiderSet based on the latest available SEC Form 13F filings for the quarter ended June 30, 2026. The institutional investors covered on this page collectively reported approximately $198.47M in KROS holdings during the latest filing period.

Blackrock, Inc. is currently the largest disclosed institutional shareholder of KROS tracked by InsiderSet, reporting ownership valued at approximately $29.90M in its June 30, 2026 SEC Form 13F filing. Based on current market prices and the latest disclosed share count, the position is now estimated to be worth approximately $32.08M, representing an estimated gain of +7.29% since the filing period.

The top 10 institutional shareholders tracked on this page collectively account for approximately 54% of the total disclosed KROS value among the investors covered in this analysis. Major shareholders include Blackrock, Inc., Nantahala Capital Management, Llc, Aqr Capital Management Llc, and several other long-term asset managers with concentrated positions in KEROS THERAPEUTICS INC (KROS).

This page ranks the largest institutional KROS shareholders using publicly disclosed SEC Form 13F data, including reported values, estimated current holding values, portfolio allocation percentages, ownership concentration metrics, and historical holding changes across major hedge funds and investment firms.

Institutional Holders

131

Total Reported Value

$198.47M

Largest Holder

Blackrock, Inc.

Largest Position

$29.90M

Insider Transactions (90d)

7

Latest Filing Quarter

Q2 2026

New Institutional Positions

104

Funds Exiting Positions

0

NameInvestor/ManagerPortfolio %QuantityReported BalanceCurrent Estimated ValueGain/loss Since FilingEstimated Portfolio Performance
Blackrock, Inc.0.00%2,794,217$29,898,120$32,077,611+$2,179,491+7.29%
Nantahala Capital Management, Llc0.91%1,410,419$15,091,483$16,191,610+$1,100,127+7.29%
Aqr Capital Management Llc0.00%967,859$10,356,092$11,111,021+$754,929+7.29%
Vanguard Capital Management Llc0.00%833,596$8,919,477$9,569,682+$650,205+7.29%
Orbimed Advisors Llc0.15%759,155$8,122,959$8,715,099+$592,140+7.29%
Federated Hermes, Inc.0.01%700,427$7,494,569$8,040,902+$546,333+7.29%
Vanguard Portfolio Management Llc0.00%652,635$6,983,195$7,492,250+$509,055+7.29%
Mackenzie Financial Corp0.01%628,438$6,724,287$7,214,468+$490,181+7.29%
Madison Avenue Partners, Lp0.29%626,583$6,704,438$7,193,173+$488,735+7.29%
Qube Research & Technologies Ltd0.01%608,837$6,514,556$6,989,449+$474,893+7.29%
Jacobs Levy Equity Management, Inc0.02%605,445$6,478,262$6,950,509+$472,247+7.29%
State Street Corp0.00%541,193$5,790,765$6,212,896+$422,131+7.29%
Geode Capital Management, Llc0.00%510,841$5,467,568$5,864,455+$396,887+7.26%
Dimensional Fund Advisors Lp0.00%460,541$4,928,290$5,287,011+$358,721+7.28%
Citadel Advisors Llc0.00%396,098$4,238,249$4,547,205+$308,956+7.29%
Renaissance Technologies LLCJim Simons0.01%359,086$3,842,220$4,122,307+$280,087+7.29%
D. E. Shaw & Co., Inc.0.00%267,460$2,861,822$3,070,441+$208,619+7.29%
Bridgeway Capital Management, Llc0.05%265,017$2,835,682$3,042,395+$206,713+7.29%
Nuveen, Llc0.00%247,756$2,650,989$2,844,239+$193,250+7.29%
Adar1 Capital Management, Llc0.12%246,818$2,640,953$2,833,471+$192,518+7.29%
Two Sigma Investments, Lp0.00%246,649$2,639,144$2,831,531+$192,387+7.29%
Arrowstreet Capital, Limited Partnership0.00%233,175$2,494,973$2,676,849+$181,876+7.29%
Millennium Management Llc0.00%184,822$1,977,595$2,121,757+$144,162+7.29%
Goldman Sachs Group Inc0.00%177,846$1,902,953$2,041,672+$138,719+7.29%
Charles Schwab Investment Management Inc0.00%158,712$1,698,218$1,822,014+$123,796+7.29%
Man Group Plc0.00%155,541$1,664,289$1,785,611+$121,322+7.29%
Wells Fargo & Company/Mn0.00%155,480$1,663,636$1,784,910+$121,274+7.29%
Northern Trust Corp0.00%153,843$1,646,121$1,766,118+$119,997+7.29%
Bessemer Group Inc0.00%143,853$1,539,000$1,651,432+$112,432+7.31%
Empowered Funds, Llc0.01%142,151$1,521,016$1,631,893+$110,877+7.29%
Ubs Group Ag0.00%137,987$1,476,461$1,584,091+$107,630+7.29%
Vanguard Fiduciary Trust Co0.00%131,314$1,405,060$1,507,485+$102,425+7.29%
Connor, Clark & Lunn Investment Management Ltd.0.00%127,885$1,368,370$1,468,120+$99,750+7.29%
O'Shaughnessy Asset Management, Llc0.01%126,379$1,352,255$1,450,831+$98,576+7.29%
Jane Street Group, Llc0.00%115,267$1,233,357$1,323,265+$89,908+7.29%
Acadian Asset Management Llc0.00%115,618$1,233,000$1,327,295+$94,295+7.65%
Bank Of New York Mellon Corp0.00%103,339$1,105,726$1,186,332+$80,606+7.29%
Ameriprise Financial Inc0.00%101,342$1,084,360$1,163,406+$79,046+7.29%
American Century Companies Inc0.00%84,680$906,076$972,126+$66,050+7.29%
Los Angeles Capital Management Llc0.00%84,372$902,781$968,591+$65,810+7.29%
Morgan Stanley0.00%79,286$848,366$910,203+$61,837+7.29%
Invesco Ltd.0.00%71,563$765,724$821,543+$55,819+7.29%
Hsbc Holdings Plc0.00%69,926$761,494$802,750+$41,256+5.42%
Martingale Asset Management L P0.02%67,796$725,418$778,298+$52,880+7.29%
Principal Financial Group Inc0.00%63,807$682,735$732,504+$49,769+7.29%
Rbf Capital, Llc0.03%62,800$671,960$720,944+$48,984+7.29%
Russell Investments Group, Ltd.0.00%60,892$651,546$699,040+$47,494+7.29%
Xtx Topco Ltd0.01%59,531$636,982$683,416+$46,434+7.29%
Jain Global Llc0.01%59,209$633,536$679,719+$46,183+7.29%
Price T Rowe Associates Inc0.00%56,121$601,000$644,269+$43,269+7.20%
Showing 50 of 131

Frequently asked questions about KROS

  • Who owns the most KROS stock?

    The largest holders of KROS are typically major institutional investors such as asset managers and hedge funds reporting on Form 13F. The table above ranks tracked superinvestors by reported position size using the latest available filings for KEROS THERAPEUTICS INC (KROS).

  • Is KROS widely held by superinvestors?

    Many widely followed stocks like KROS appear across numerous superinvestor portfolios because of liquidity, index inclusion, and fundamentals. The holder count and table above show how broadly KROS is represented among the institutional managers we track.

  • What do “Current Estimated Value”, “Gain/loss Since Filing”, and “Estimated Portfolio Performance” mean?

    Current Estimated Value is reported share quantity from the latest 13F times our most recent split-adjusted U.S. session close. Gain/loss Since Filing is that estimate minus the reported 13F dollar value; Estimated Portfolio Performance is that difference as a percent of the reported value. Green means the estimate is above the filing value; red means below (not purchase cost). If many filers share the same implied filing price per share, the performance % may match across rows. These are not official fund marks or live quotes.